303 related articles for article (PubMed ID: 27536994)
1. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait.
Jamal WY; Rotimi VO
PLoS One; 2016; 11(8):e0161411. PubMed ID: 27536994
[TBL] [Abstract][Full Text] [Related]
2. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
[TBL] [Abstract][Full Text] [Related]
3. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
5. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
[TBL] [Abstract][Full Text] [Related]
6. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
[TBL] [Abstract][Full Text] [Related]
7. Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment.
Tian TT; Zhao JH; Yang J; Qiang CX; Li ZR; Chen J; Xu KY; Ciu QQ; Li RX
PLoS One; 2016; 11(3):e0151964. PubMed ID: 27011211
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile epidemic strain far reaching.
Quirk M
Lancet Infect Dis; 2006 Feb; 6(2):74. PubMed ID: 16456988
[No Abstract] [Full Text] [Related]
9. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
Kim J; Kang JO; Kim H; Seo MR; Choi TY; Pai H; Kuijper EJ; Sanders I; Fawley W
Clin Microbiol Infect; 2013 Jun; 19(6):521-7. PubMed ID: 22712697
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait.
Jamal WY; Mokaddas EM; Verghese TL; Rotimi VO
Int J Antimicrob Agents; 2002 Oct; 20(4):270-4. PubMed ID: 12385683
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
[TBL] [Abstract][Full Text] [Related]
14. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile.
Kwon SS; Gim JL; Kim MS; Kim H; Choi JY; Yong D; Lee K
Anaerobe; 2017 Dec; 48():42-46. PubMed ID: 28655581
[TBL] [Abstract][Full Text] [Related]
16. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
[TBL] [Abstract][Full Text] [Related]
17. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK.
John R; Brazier JS
J Hosp Infect; 2005 Sep; 61(1):11-4. PubMed ID: 16002183
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
[TBL] [Abstract][Full Text] [Related]
20. Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
Miller-Roll T; Na'amnih W; Cohen D; Carmeli Y; Adler A
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):450-454. PubMed ID: 27638350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
